Immunogenicity and safety of the Moderna vaccine in organ transplant recipients

Antibody levels, cell-mediated immunity, and safety were evaluated in solid organ transplant recipients who received two doses of the Moderna vaccine. Key findings from this study are as follows: 65.5% of patients had no detectable antibody (anti-RBD) response following the second vaccine dose; 73.1% were not able to neutralize the virus after the second … Continue reading Immunogenicity and safety of the Moderna vaccine in organ transplant recipients